Skip to content

Carver Kyle

Reporting owner on Forms 3, 4 and 5, CIK 1757072.

Carver Kyle reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-17.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Evommune, Inc. CIK 2044725officer (Chief Financial Officer)12026-11-17

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
EVMN · Evommune, Inc.Stock Option (Right to buy), derivative2026-11-13D returned to the issuer-279,4080Form 4
EVMN · Evommune, Inc.Stock Option (Right to buy), derivative2026-11-13A granted+279,408279,408Form 4
EVMN · Evommune, Inc.Stock Option (Right to buy), derivative2026-11-13D returned to the issuer-98,9460Form 4
EVMN · Evommune, Inc.Stock Option (Right to buy), derivative2026-11-13A granted+98,94698,946Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001757072-26-000009 Evommune, Inc.2026-11-17